Karen Keeshan
13PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Mar 13, 2026
Inducing TRIB2-targeted protein degradation to reverse chemoresistance in acute myeloid leukaemia.Evie Rigby, Francesca Fasanella Masci, Akshara Narayanan
|Nov 11, 2024
Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact-independent mechanism.Alison Laing, Ahmed Elmarghany, Arwa A Alghaith
|Feb 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness.Chiara Pirillo, Flora Birch, Floriane S Tissot
|Jul 02, 2021
Structure vs. Function of TRIB1-Myeloid Neoplasms and Beyond.Hamish D McMillan, Karen Keeshan, Anita K Dunbier
|Jan 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AML.Anne-Louise Latif, Ashley Newcombe, Sha Li
|Jan 09, 2021
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.Myint Myat Khine Aung, Megan L Mills, Joana Bittencourt-Silvestre
Pageof 3
Frequent Collaborators
1 joint publications
Daniel M Foulkes
1 joint publications
Wayland Yeung
1 joint publications
Safal Shrestha
1 joint publications
Claire E Eyers
1 joint publications
Carrow Wells
1 joint publications
David H Drewry
1 joint publications
William J Zuercher
1 joint publications
Patrick A Eyers
1 joint publications
Joana Bittencourt-Silvestre
1 joint publications
Evgenia Sarrou
